ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,507,960, issued on Dec. 30, was assigned to Medtronic Inc. (Minneapolis).

"Using biomarker information for heart failure risk computation" was invented by Vinod Sharma (Maple Grove, Minn.), Eduardo N. Warman (Maple Grove, Minn.), Yong K. Cho (Excelsior, Minn.) and Shantanu Sarkar (Roseville, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a method, system and/or apparatus for determining prospective heart failure event risk. Acquired from a device memory are a heart failure patient's current and preceding risk assessment periods. Counting detected data observations in the current risk assessment period for a current risk assessment tota...